Arthur Tzianabos, CEO of Homology Medicines, discusses the company’s genetic therapies, its program in PKU, and how it pairs its vectors and approach to meet the needs of a given condition. @globalgenes #RARECast

A Bet on a Unique Set of Vectors

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share A Bet on a Unique Set of Vectors

Sign up to save your podcasts

A Bet on a Unique Set of Vectors

A Bet on a Unique Set of Vectors